Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM
- 13 November 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 26 (17), 2185-2192
- https://doi.org/10.1097/qad.0b013e328359f255
Abstract
Objective: Anal cancer incidence is high in HIV-infected MSM. Screening for anal intraepithelial lesions and cancers is performed at specialized clinics and relies on high-resolution anoscopy (HRA) and anal cytology. Both approaches have limited reproducibility and sensitivity for detecting anal cancer precursors. We evaluated biomarkers for human papillomavirus (HPV)-related disease in a population of HIV-infected MSM. Methods: A cross-sectional screening study with passive follow-up included 363 MSM followed at a HIV/AIDS clinic. All men had anal cytology samples taken and were evaluated using HRA and anal biopsies. Using a composite endpoint of biopsy results and cytology, we compared the performance of HPV16/18 genotyping, HPVE6/E7 mRNA expression, and p16/Ki-67 cytology to detect high-grade anal intraepithelial neoplasias (AINs). Results: For all biomarkers analyzed, there was a significant trend of increasing percentage of men testing positive with increasing severity of disease (P < 0.001). HPV DNA testing had the highest sensitivity for anal intraepithelial neoplasia grade 2 and anal intraepithelial neoplasia grade 3 (AIN3), followed by p16/Ki-67, HPVE6/E7 mRNA testing, and HPV16/18 genotyping. The highest Youden's index was observed for HPVE6/E7 mRNA testing, followed by HPV16/18 genotyping, p16/Ki-67 cytology, and HPV DNA testing. Increasing the threshold for positivity of p16/Ki-67 to five or more positive cells led to significantly higher specificity, but unchanged sensitivity for detecting AIN3. Conclusion: Molecular features of anal disease categories are similar to those of corresponding cervical lesions. Biomarkers evaluated for cervical cancer screening may be used for primary anal cancer screening or to decide who should require immediate treatment vs. expectant management.Keywords
This publication has 22 references indexed in Scilit:
- The Changing Picture of High-grade Anal Intraepithelial Neoplasia in Men Who Have Sex With Men: The Effects of 10 Years of Experience Performing High-resolution AnoscopyDiseases of the Colon & Rectum, 2011
- Human Papillomavirus Testing in the Prevention of Cervical CancerJNCI Journal of the National Cancer Institute, 2011
- Anal cancer and cervical cancer screening: Key differencesCancer Cytopathology, 2010
- Hierarchical Clustering of Human Papilloma Virus Genotype Patterns in the ASCUS-LSIL Triage StudyCancer Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Risk of Human Papillomavirus–Associated Cancers Among Persons With AIDSJNCI Journal of the National Cancer Institute, 2009
- How to evaluate emerging technologies in cervical cancer screening?International Journal of Cancer, 2009
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysisInternational Journal of Cancer, 2009
- Human papillomavirus-related disease in people with HIVCurrent Opinion in HIV and AIDS, 2009
- Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in OklahomaInternational Journal of Cancer, 2008